Source: Annual Congress 2009 - Tuberculosis contact screening
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Losi, G. Corona, C. Del Giovane, P. Roversi, R. D‘Amico, P. Marchegiano, F. Rumpianesi, M. Meacci, B. Meccugni, G. Franco, L. Fabbri, L. Richeldi (Modena, Italy). Using QuantiFERON-TB gold in-tube in contact tracing procedures. Eur Respir J 2009; 34: Suppl. 53, 495

Member's Comments

BOTHAMLEY Graham H. - 13.09.2009 12:27
Health care workers
So BCG vaccination prevents immune responses to esat-6 and crp10 (?primary antigenic sin - no response to new epitopes)

Related content which might interest you: Short-term reproducibility of the QuantiFERON-TB gold in-tube assay Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Programmatic experience with QuantiFERON-TB gold in-tube assay for contact screening in congregate settings in Singapore Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 QuantiFERON-TB gold in tube method in sarcoidosis patients Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Source: Eur Respir J 2016; 48: 1411-1419 Year: 2016 Use of QuantiFERON-TB gold test in diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 140s Year: 2006 Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016 Year: 2017 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 133s Year: 2007 The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts Source: Eur Respir J 2008; 32: 524-525 Year: 2008 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 First independent evaluation of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 47:1587-1590 Year: 2016 Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step? Source: Eur Respir J 2015; 46: 1506-1509 Year: 2015 Evaluation of latent tuberculosis infection in health care workers by QuantiFERON-TB Gold test and tuberculin skin test Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Practical use of quantiferon test in Norway‘s largest TB-clinic Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 953-954 Year: 2016 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 955-956 Year: 2016